I am still bullish about Renhuang (RHGP) and Rodobo (RDBO). The first one because of valuation but also because they are marketleader in some traditional Chinese medicines, so that would lead to nice growth figures the coming years.
Rodobo, because I really think they can pull it of. The trend in China because of the milk scandals is now that Chinese consumers are looking for reliable more expensive milk products. Of course foreign enterprises (Nestlé, Danone, etc.) will profit from it, but I think also Rodobo is good positioned to get a nice piece of the cake. If not, I think it will be a nice take-over candidate in some years.